ContributorsPublishersAdvertisers

Dr. Burger on the Benefits of Novel Combination Approaches in CLL

onclive.com
 2022-01-13

Jan A. Burger, MD, PhD, discusses the benefit of combination therapy in patients with chronic lymphocytic leukemia. Jan A. Burger, MD, PhD, tenured professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center,...

www.onclive.com

Comments / 0

Comments / 0